This study aims to uncover why maggot therapy is not used more often, particularly in the context of antimicrobial resistance infections, and to determine what can be done to ensure MT is more effectively used in the future to improve patient outcomes and manage the growing problem of AMR. To read the full article, choose Open Athens “Institutional Login” and search for “Midlands Partnership”.